most admired leader Ramanathan

Posted 23 hours ago

Ramesh K. Ramanathan, MD: Advancing Cancer Care Through Innovation and Leadership

Ramesh K. Ramanathan, MD, has been named one of the Most Admired Leaders in the Phoenix Valley by the Phoenix Business Journal, a recognition that highlights his lasting impact on advancing better cancer outcomes across the region. As Medical Director of Clinical Research at Ironwood Cancer & Research Centers in Scottsdale, Arizona, Dr. Ramanathan brings a unique combination of academic expertise and pharmaceutical industry leadership to the forefront of cancer care and research.

Professional Background

Dr. Ramanathan is a board-certified medical oncologist and serves as Medical Director of Clinical Research at Ironwood Cancer & Research Centers. His distinguished career spans leadership roles in both clinical practice and industry, including serving as Executive Director of Global Scientific Affairs at Merck Research Laboratories and Vice President at ZielBio. He previously held faculty appointments at Mayo Clinic in Phoenix (2014–2018), alongside a joint role at TGen.

Earlier in his career, Dr. Ramanathan led major clinical research programs, including serving as medical director of the Virginia G. Piper Cancer Center Clinical Trials Program (2007–2014) and holding a leadership role at the University of Pittsburgh Cancer Institute (1996–2007). His expertise centers on gastrointestinal cancers, clinical trials, and the development of novel cancer therapies.

Contributions to Medicine

Over more than 25 years, Dr. Ramanathan has played a critical role in advancing cancer treatment and drug development. His contributions include helping bring key therapies to patients, such as oxaliplatin for colon cancer and nab-paclitaxel for pancreatic cancer.

He has also led the development of innovative targeted therapies, including PARP inhibitors, PI3K inhibitors, hedgehog pathway inhibitors, and liposomal drug formulations. His commitment to advancing oncology research is reflected in his publication record, with more than 200 peer-reviewed articles and numerous book chapters.

In addition to his research contributions, Dr. Ramanathan has served on national professional committees and is a sought-after speaker at leading international oncology conferences.

Recognized Leadership

Being named to the 2026 Most Admired Leaders list underscores Dr. Ramanathan’s visionary leadership and dedication to improving patient outcomes through cutting-edge clinical research. His work bridges the gap between scientific discovery and patient-centered care, ensuring that emerging therapies translate into meaningful advances for patients.

Through his leadership at Ironwood Cancer & Research Centers, Dr. Ramanathan continues to shape the future of oncology—driving innovation, expanding access to clinical trials, by ensuring patients can participate in clinical trials without traveling more than 20 miles from home and delivering compassionate, high-quality care to the communities Ironwood serves.